BeStock  
Markets › Compare › ANAB vs ADRX

ANAB vs ADRX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ANAB · AnaptysBio$46.63 ▼ 1.62%
ADRX · Adarx Pharmaceuticals$12.79 ▼ 9.68%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

64758698109Sep 25, '26Oct 23, '26Nov 20, '26
  • ANAB -8.6%
  • ADRX -33.9%

Head to head

MetricANABADRX
Price$46.63$12.79
Change today▼ 1.62%▼ 9.68%
Market cap$1.39B$1.42B
Return, 3 months-20.2%–
Return, year to date+44.3%–
Return, 1 year+76.6%–
P/E (TTM)9.0–
P/B66.62.5
P/E percentile vs own 5y93rd85th
Dividend yield––
Revenue growth (YoY, latest qtr)+18.5%+258.7%
Net profit growth (YoY)+107.3%-42.4%
Gross margin––
Operating margin65.7%-1,735.0%
Net margin12.8%-1,434.1%
Return on equity––
Analyst target vs. price+71.6%+173.7%
Analyst buy share100%100%
RSI (14)4535
30-day volatility47.9%78.8%
Max drawdown, 1 year-34.9%-38.0%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ADRX is the largest of the group by market value.
  • ADRX is growing revenue fastest.
  • ANAB keeps the most profit per dollar of sales.
  • ANAB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top